| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 9.86e-05 | 25 | 12 | 2 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1.07e-04 | 26 | 12 | 2 | GO:0016701 | |
| GeneOntologyMolecularFunction | cholesterol binding | 5.37e-04 | 58 | 12 | 2 | GO:0015485 | |
| GeneOntologyMolecularFunction | sterol binding | 8.04e-04 | 71 | 12 | 2 | GO:0032934 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.52e-03 | 98 | 12 | 2 | GO:0051213 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.65e-03 | 102 | 12 | 2 | GO:0043178 | |
| GeneOntologyMolecularFunction | hormone binding | 1.68e-03 | 103 | 12 | 2 | GO:0042562 | |
| GeneOntologyMolecularFunction | steroid binding | 2.78e-03 | 133 | 12 | 2 | GO:0005496 | |
| GeneOntologyMolecularFunction | iron ion binding | 4.29e-03 | 166 | 12 | 2 | GO:0005506 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 4.60e-03 | 172 | 12 | 2 | GO:0044325 | |
| GeneOntologyMolecularFunction | isomerase activity | 5.70e-03 | 192 | 12 | 2 | GO:0016853 | |
| GeneOntologyMolecularFunction | lyase activity | 6.90e-03 | 212 | 12 | 2 | GO:0016829 | |
| GeneOntologyBiologicalProcess | hepoxilin metabolic process | 7.23e-06 | 8 | 11 | 2 | GO:0051121 | |
| GeneOntologyBiologicalProcess | hepoxilin biosynthetic process | 7.23e-06 | 8 | 11 | 2 | GO:0051122 | |
| GeneOntologyBiologicalProcess | lipoxygenase pathway | 1.42e-05 | 11 | 11 | 2 | GO:0019372 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 6.50e-05 | 23 | 11 | 2 | GO:0043651 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 1.04e-04 | 29 | 11 | 2 | GO:0042759 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 2.10e-04 | 41 | 11 | 2 | GO:0061436 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | 3.03e-04 | 260 | 11 | 3 | GO:0072330 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 5.78e-04 | 68 | 11 | 2 | GO:0019369 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | 6.33e-04 | 813 | 11 | 4 | GO:0008610 | |
| GeneOntologyBiologicalProcess | ceramide biosynthetic process | 6.66e-04 | 73 | 11 | 2 | GO:0046513 | |
| GeneOntologyBiologicalProcess | bicellular tight junction assembly | 8.19e-04 | 81 | 11 | 2 | GO:0070830 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol transport | 8.59e-04 | 83 | 11 | 2 | GO:0032374 | |
| GeneOntologyBiologicalProcess | regulation of sterol transport | 8.59e-04 | 83 | 11 | 2 | GO:0032371 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 8.76e-04 | 374 | 11 | 3 | GO:0046394 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 8.96e-04 | 377 | 11 | 3 | GO:0016053 | |
| GeneOntologyBiologicalProcess | tight junction assembly | 9.65e-04 | 88 | 11 | 2 | GO:0120192 | |
| GeneOntologyBiologicalProcess | apical junction assembly | 1.01e-03 | 90 | 11 | 2 | GO:0043297 | |
| GeneOntologyBiologicalProcess | tight junction organization | 1.10e-03 | 94 | 11 | 2 | GO:0120193 | |
| GeneOntologyBiologicalProcess | ceramide metabolic process | 1.58e-03 | 113 | 11 | 2 | GO:0006672 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 1.70e-03 | 117 | 11 | 2 | GO:0030148 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 1.90e-03 | 124 | 11 | 2 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.03e-03 | 128 | 11 | 2 | GO:0033559 | |
| GeneOntologyBiologicalProcess | lipid oxidation | 2.06e-03 | 129 | 11 | 2 | GO:0034440 | |
| GeneOntologyBiologicalProcess | cholesterol transport | 2.22e-03 | 134 | 11 | 2 | GO:0030301 | |
| GeneOntologyBiologicalProcess | sterol transport | 2.38e-03 | 139 | 11 | 2 | GO:0015918 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 2.49e-03 | 142 | 11 | 2 | GO:0006690 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 3.03e-03 | 157 | 11 | 2 | GO:0046467 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 3.38e-03 | 166 | 11 | 2 | GO:0098773 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 3.42e-03 | 167 | 11 | 2 | GO:0007043 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 3.62e-03 | 172 | 11 | 2 | GO:0043604 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 3.79e-03 | 176 | 11 | 2 | GO:0006665 | |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 3.91e-03 | 179 | 11 | 2 | GO:0032368 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 3.96e-03 | 180 | 11 | 2 | GO:0120254 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 4.07e-03 | 1342 | 11 | 4 | GO:0033043 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 4.44e-03 | 191 | 11 | 2 | GO:0006633 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 4.75e-03 | 676 | 11 | 3 | GO:0044283 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 5.29e-03 | 209 | 11 | 2 | GO:0006694 | |
| GeneOntologyBiologicalProcess | lipid modification | 5.54e-03 | 214 | 11 | 2 | GO:0030258 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 5.59e-03 | 215 | 11 | 2 | GO:1905952 | |
| GeneOntologyBiologicalProcess | RNA localization | 5.69e-03 | 217 | 11 | 2 | GO:0006403 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.22e-04 | 29 | 12 | 2 | GO:0097038 | |
| HumanPheno | Intellectual disability, borderline | 3.61e-06 | 25 | 7 | 3 | HP:0006889 | |
| HumanPheno | Palmar hyperlinearity | 3.39e-05 | 7 | 7 | 2 | HP:0033252 | |
| HumanPheno | Thin nail | 1.92e-04 | 16 | 7 | 2 | HP:0001816 | |
| Domain | LIPOXYGENASE_1 | 5.67e-06 | 6 | 12 | 2 | PS00711 | |
| Domain | LipOase_C | 5.67e-06 | 6 | 12 | 2 | IPR013819 | |
| Domain | LIPOXYGENASE_2 | 5.67e-06 | 6 | 12 | 2 | PS00081 | |
| Domain | LipOase | 5.67e-06 | 6 | 12 | 2 | IPR000907 | |
| Domain | Lipoxygenase | 5.67e-06 | 6 | 12 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 5.67e-06 | 6 | 12 | 2 | PS51393 | |
| Domain | LipOase_Fe_BS | 5.67e-06 | 6 | 12 | 2 | IPR020833 | |
| Domain | LipOase_CS | 5.67e-06 | 6 | 12 | 2 | IPR020834 | |
| Domain | LipOase_mml | 5.67e-06 | 6 | 12 | 2 | IPR001885 | |
| Domain | LH2 | 5.76e-05 | 18 | 12 | 2 | SM00308 | |
| Domain | PLAT | 7.89e-05 | 21 | 12 | 2 | PS50095 | |
| Domain | PLAT/LH2_dom | 7.89e-05 | 21 | 12 | 2 | IPR001024 | |
| Domain | - | 7.89e-05 | 21 | 12 | 2 | 2.60.60.20 | |
| Domain | PLAT | 7.89e-05 | 21 | 12 | 2 | PF01477 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 1.16e-05 | 7 | 11 | 2 | M27139 | |
| Pathway | REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES | 1.16e-05 | 7 | 11 | 2 | MM14860 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 3.64e-05 | 12 | 11 | 2 | M48064 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 5.87e-04 | 47 | 11 | 2 | M39531 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 9.24e-04 | 59 | 11 | 2 | M27140 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 9.55e-04 | 620 | 11 | 4 | MM15193 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 9.88e-04 | 61 | 11 | 2 | MM14861 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.01e-03 | 757 | 11 | 4 | M27451 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 3.23e-03 | 111 | 11 | 2 | M48065 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 4.14e-03 | 126 | 11 | 2 | MM15553 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 6.11e-03 | 154 | 11 | 2 | M27832 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 7.40e-03 | 170 | 11 | 2 | MM15573 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 7.92e-03 | 176 | 11 | 2 | M27854 | |
| Pubmed | 12R-lipoxygenase deficiency disrupts epidermal barrier function. | 1.09e-07 | 2 | 12 | 2 | 17403930 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 11773004 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 15629692 | ||
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 21558561 | ||
| Pubmed | Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients. | 1.09e-07 | 2 | 12 | 2 | 33435499 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 19131948 | ||
| Pubmed | The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier. | 1.09e-07 | 2 | 12 | 2 | 24021977 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 17139268 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 22832496 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 10366447 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 19890349 | ||
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 23954555 | ||
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 11350124 | ||
| Pubmed | 6.55e-07 | 4 | 12 | 2 | 22622417 | ||
| Pubmed | 1.09e-06 | 5 | 12 | 2 | 17436029 | ||
| Pubmed | 8.49e-06 | 13 | 12 | 2 | 20301593 | ||
| Pubmed | 1.86e-05 | 19 | 12 | 2 | 28369476 | ||
| Pubmed | 3.26e-05 | 25 | 12 | 2 | 19092943 | ||
| Interaction | CCDC27 interactions | 3.40e-05 | 15 | 12 | 2 | int:CCDC27 | |
| Interaction | ZNF154 interactions | 1.22e-04 | 28 | 12 | 2 | int:ZNF154 | |
| Interaction | B3GALNT1 interactions | 1.40e-04 | 30 | 12 | 2 | int:B3GALNT1 | |
| Interaction | SFR1 interactions | 2.14e-04 | 37 | 12 | 2 | int:SFR1 | |
| Interaction | IFNA4 interactions | 2.63e-04 | 41 | 12 | 2 | int:IFNA4 | |
| Interaction | GALNT9 interactions | 3.17e-04 | 45 | 12 | 2 | int:GALNT9 | |
| Cytoband | 17p13.1 | 4.25e-04 | 118 | 12 | 2 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q31 | 9.62e-04 | 178 | 12 | 2 | chr2q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.56e-03 | 346 | 12 | 2 | chr17p13 | |
| GeneFamily | Arachidonate lipoxygenases | 2.57e-06 | 6 | 8 | 2 | 407 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 7.74e-07 | 41 | 12 | 3 | M2000 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 8.33e-07 | 42 | 12 | 3 | MM1275 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | 1.52e-06 | 199 | 12 | 4 | M9345 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP | 7.03e-05 | 183 | 12 | 3 | M6670 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN | 9.15e-05 | 200 | 12 | 3 | M5975 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 9.15e-05 | 200 | 12 | 3 | M8690 | |
| Coexpression | GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP | 9.15e-05 | 200 | 12 | 3 | M5842 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 183 | 12 | 3 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.26e-05 | 54 | 12 | 2 | 13431c23a110070a11de41773233a8d6583d902c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.26e-05 | 54 | 12 | 2 | cd64ee5c47df5dba0cea954cb115a8de0efb55d1 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.61e-05 | 55 | 12 | 2 | 21a72cc6f12889509dbfaa9929be48d00f5f6345 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.61e-05 | 55 | 12 | 2 | 6575ee5274f1044e17f4a5204375acc82ef16182 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_Nucleus_(STN),_maybe_ENT_as_well)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.30e-04 | 64 | 12 | 2 | ce0c117d29057640f2be09c3a4cde7733bf2f5ac | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.30e-04 | 64 | 12 | 2 | 5bfbacbd39dd176a29703e2a99644b465a50c655 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.30e-04 | 64 | 12 | 2 | f56966e8f54db8f973533166e0ae4dd829a390c9 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_Nucleus_(STN),_maybe_ENT_as_well)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.30e-04 | 64 | 12 | 2 | 77fcb80a2c56aef754dd5eb327a39c698766ebcf | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 94 | 12 | 2 | 2fb80a08f823295fa4c3e6494bf020e5b4052f0f | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 94 | 12 | 2 | d25f096626af873f724a8cd6454ed56e33fd9854 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-04 | 127 | 12 | 2 | eee8e4a83f7de46807440d202d46eee7dd722001 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-04 | 132 | 12 | 2 | 182973660929fe4174e0354c85863a25518c18c1 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.87e-04 | 136 | 12 | 2 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.87e-04 | 136 | 12 | 2 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-04 | 141 | 12 | 2 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-04 | 141 | 12 | 2 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-04 | 142 | 12 | 2 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.94e-04 | 148 | 12 | 2 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.94e-04 | 148 | 12 | 2 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 7.51e-04 | 154 | 12 | 2 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 7.71e-04 | 156 | 12 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.71e-04 | 156 | 12 | 2 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 7.71e-04 | 156 | 12 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.71e-04 | 156 | 12 | 2 | 27590a4d2b419644966f0037c67c761fc275e0aa | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.90e-04 | 158 | 12 | 2 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.90e-04 | 158 | 12 | 2 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.90e-04 | 158 | 12 | 2 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.00e-04 | 159 | 12 | 2 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.00e-04 | 159 | 12 | 2 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-04 | 161 | 12 | 2 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-04 | 161 | 12 | 2 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-04 | 163 | 12 | 2 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.41e-04 | 163 | 12 | 2 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 163 | 12 | 2 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.51e-04 | 164 | 12 | 2 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.51e-04 | 164 | 12 | 2 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.51e-04 | 164 | 12 | 2 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 164 | 12 | 2 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 164 | 12 | 2 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 164 | 12 | 2 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-04 | 165 | 12 | 2 | 50f1fa7434ebb777e15d5273d1ff41070cff6db3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.61e-04 | 165 | 12 | 2 | 8a278e72a9a779152de78b6bd55567d82941c5aa | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 9.35e-04 | 172 | 12 | 2 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.46e-04 | 173 | 12 | 2 | 90e3b9ea3d5f565cfc669e33c4d805b2940a09b3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-04 | 173 | 12 | 2 | a8ee017938dd4705361e6fd9a17061ab927027f4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-04 | 173 | 12 | 2 | c1e443c611e6f88ccbba6c019895437aa986414b | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.57e-04 | 174 | 12 | 2 | 46838b4bb9b4d8ce5e1c608a700e7f393bc52658 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.57e-04 | 174 | 12 | 2 | 103594eeb600eb5bc9cbf09a65b286b3a3a18cdc | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.68e-04 | 175 | 12 | 2 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-04 | 175 | 12 | 2 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 9.79e-04 | 176 | 12 | 2 | 50fe3fd862dd6a6550ebb8c27f337cde468efedc | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 178 | 12 | 2 | 0f85602f652235b19d208e837896f32081052d3d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-03 | 179 | 12 | 2 | 3d3716078afdb9a89ddfadb3197cd1b52fa770be | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-03 | 179 | 12 | 2 | c7d7a66fca6a41de0af3cc2b75a29a54456842cd | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 180 | 12 | 2 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 183 | 12 | 2 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-03 | 184 | 12 | 2 | 65b00145cb7da7d64eb6765569573c1a902a1036 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.07e-03 | 184 | 12 | 2 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-03 | 184 | 12 | 2 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.07e-03 | 184 | 12 | 2 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-03 | 185 | 12 | 2 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-03 | 185 | 12 | 2 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-03 | 185 | 12 | 2 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-03 | 186 | 12 | 2 | e4de270d38bbed022f545bd0bbaa9599e707ec87 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 186 | 12 | 2 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.09e-03 | 186 | 12 | 2 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-03 | 187 | 12 | 2 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.10e-03 | 187 | 12 | 2 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-03 | 187 | 12 | 2 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-03 | 188 | 12 | 2 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.13e-03 | 189 | 12 | 2 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.13e-03 | 189 | 12 | 2 | cce6602ad68c177985a5e43cfb2776d615cfbca0 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-03 | 190 | 12 | 2 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-03 | 190 | 12 | 2 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.14e-03 | 190 | 12 | 2 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-03 | 190 | 12 | 2 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.14e-03 | 190 | 12 | 2 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.14e-03 | 190 | 12 | 2 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.14e-03 | 190 | 12 | 2 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-03 | 190 | 12 | 2 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-03 | 190 | 12 | 2 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.15e-03 | 191 | 12 | 2 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-03 | 192 | 12 | 2 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.16e-03 | 192 | 12 | 2 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-03 | 192 | 12 | 2 | c7185fbc56ffd4c62db47fc240b3207ef65db40e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.16e-03 | 192 | 12 | 2 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 193 | 12 | 2 | 264785a88583fd4bbb2ed2e9a7a78bbed539e0ed | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-03 | 193 | 12 | 2 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-03 | 193 | 12 | 2 | b1893193766ae41bf2ab6ed4083285c9c814e608 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Monocytes|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.17e-03 | 193 | 12 | 2 | e67e960a5312ed73c5169795cb282e431866b9c1 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-03 | 193 | 12 | 2 | 55eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818 | |
| ToppCell | Monocytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-03 | 194 | 12 | 2 | ed14fbb3b4622798f8e02dc91bbe464a6fed8310 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.19e-03 | 194 | 12 | 2 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-03 | 194 | 12 | 2 | bea369e9a7018d862e4d7f1c9ec2de50f3fd38ec | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 194 | 12 | 2 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.20e-03 | 195 | 12 | 2 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-03 | 195 | 12 | 2 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | metastatic_Brain-Myeloid_cells-Monocytes|metastatic_Brain / Location, Cell class and cell subclass | 1.20e-03 | 195 | 12 | 2 | dfc24ee09bdc20d8a38feb8a4cc5f6b54a032981 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-03 | 195 | 12 | 2 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| Drug | ketoprofen | 4.58e-06 | 64 | 12 | 3 | CID000003825 | |
| Drug | 12-IODE | 5.34e-06 | 7 | 12 | 2 | CID006450050 | |
| Drug | BN 52021 | 6.81e-06 | 73 | 12 | 3 | CID000065243 | |
| Drug | colneleic acid | 7.12e-06 | 8 | 12 | 2 | CID006441681 | |
| Drug | htyA | 7.12e-06 | 8 | 12 | 2 | CID000152267 | |
| Drug | 14,15-leukotriene A4 | 9.15e-06 | 9 | 12 | 2 | CID006439604 | |
| Drug | ODYA | 9.15e-06 | 9 | 12 | 2 | CID000001931 | |
| Drug | octadeca-9,12-dien-1-ol | 9.15e-06 | 9 | 12 | 2 | CID000068168 | |
| Drug | 8,15-diHPETE | 9.15e-06 | 9 | 12 | 2 | CID005283181 | |
| Drug | 13-hydroxylinoleic acid | 9.15e-06 | 9 | 12 | 2 | CID006438633 | |
| Drug | AC1NSXHC | 9.15e-06 | 9 | 12 | 2 | CID005371969 | |
| Drug | U-66,855 | 9.15e-06 | 9 | 12 | 2 | CID000127235 | |
| Drug | AC1L1IMV | 1.12e-05 | 86 | 12 | 3 | CID000004646 | |
| Drug | 9-HPODE | 1.14e-05 | 10 | 12 | 2 | CID000001928 | |
| Drug | 1,4-pentadiene | 1.14e-05 | 10 | 12 | 2 | CID000011587 | |
| Drug | acetone phenylhydrazone | 1.40e-05 | 11 | 12 | 2 | CID000066026 | |
| Drug | Ity A | 1.40e-05 | 11 | 12 | 2 | CID000188274 | |
| Drug | nonenal | 1.68e-05 | 12 | 12 | 2 | CID003015503 | |
| Drug | 9-HETE | 1.98e-05 | 13 | 12 | 2 | CID000001926 | |
| Drug | AC1NR1Q2 | 1.98e-05 | 13 | 12 | 2 | CID005283190 | |
| Drug | AC1L1BGZ | 1.98e-05 | 13 | 12 | 2 | CID000001435 | |
| Drug | ICI207968 | 1.98e-05 | 13 | 12 | 2 | CID000129095 | |
| Drug | AC1O4E1A | 1.98e-05 | 13 | 12 | 2 | CID006365736 | |
| Drug | oxphaman | 2.31e-05 | 14 | 12 | 2 | CID005464022 | |
| Drug | AC1NR1LB | 2.31e-05 | 14 | 12 | 2 | CID005283131 | |
| Drug | timegadine | 2.31e-05 | 14 | 12 | 2 | CID000068902 | |
| Drug | 5-HEPE | 2.31e-05 | 14 | 12 | 2 | CID000001766 | |
| Drug | 17-HdoHE | 2.31e-05 | 14 | 12 | 2 | CID006439179 | |
| Drug | 8(S),15(S)-diHETE | 2.66e-05 | 15 | 12 | 2 | CID000001897 | |
| Drug | 8R-HpETE | 2.66e-05 | 15 | 12 | 2 | CID005283170 | |
| Drug | Hex-3-enyl acetate | 2.66e-05 | 15 | 12 | 2 | CID000015574 | |
| Drug | 13-HpOTrE | 2.66e-05 | 15 | 12 | 2 | CID005282866 | |
| Drug | eye gene | 3.03e-05 | 369 | 12 | 4 | CID000004782 | |
| Drug | hex-3-enal | 3.04e-05 | 16 | 12 | 2 | CID000023234 | |
| Drug | AC1NR1M2 | 3.04e-05 | 16 | 12 | 2 | CID005283140 | |
| Drug | 12R-HETrE | 3.04e-05 | 16 | 12 | 2 | CID005283149 | |
| Drug | peroxylinolenic acid | 3.04e-05 | 16 | 12 | 2 | CID006439905 | |
| Drug | ETYA | 3.19e-05 | 122 | 12 | 3 | CID000001780 | |
| Drug | 5,15-diHETE | 3.45e-05 | 17 | 12 | 2 | CID005283158 | |
| Drug | cirsiliol | 3.45e-05 | 17 | 12 | 2 | CID000160237 | |
| Drug | FPL 57231 | 3.88e-05 | 18 | 12 | 2 | CID000122212 | |
| Drug | 3-nonenal | 3.88e-05 | 18 | 12 | 2 | CID005283336 | |
| Drug | BW540C | 3.88e-05 | 18 | 12 | 2 | CID000134372 | |
| Drug | AC1O5PL5 | 3.88e-05 | 18 | 12 | 2 | CID006438380 | |
| Drug | L-651,392 | 4.81e-05 | 20 | 12 | 2 | CID000122182 | |
| Drug | TMK777 | 4.81e-05 | 20 | 12 | 2 | CID006438911 | |
| Drug | AC1L2P35 | 4.81e-05 | 20 | 12 | 2 | CID000125736 | |
| Drug | AC1O5S1P | 5.32e-05 | 21 | 12 | 2 | CID006439617 | |
| Drug | AC1NRAUB | 5.32e-05 | 21 | 12 | 2 | CID005288098 | |
| Drug | 20-carboxyleukotriene B4 | 5.32e-05 | 21 | 12 | 2 | CID000001588 | |
| Drug | 5,8,11-eicosatrienoic acid | 5.85e-05 | 22 | 12 | 2 | CID000004028 | |
| Drug | CGS 8515 | 5.85e-05 | 22 | 12 | 2 | CID000163944 | |
| Drug | diethylcarbamazine | 5.85e-05 | 22 | 12 | 2 | CID000003052 | |
| Drug | BM 13.177 | 5.85e-05 | 22 | 12 | 2 | CID000051550 | |
| Drug | L-656,224 | 6.40e-05 | 23 | 12 | 2 | CID000128132 | |
| Drug | AC1NSYHD | 6.40e-05 | 23 | 12 | 2 | CID005319705 | |
| Drug | octadecadienoic acid | 6.40e-05 | 23 | 12 | 2 | CID005312457 | |
| Drug | 13-hydroperoxylinoleic acid | 7.59e-05 | 25 | 12 | 2 | CID006438144 | |
| Drug | pinolenic acid | 7.59e-05 | 25 | 12 | 2 | CID005312493 | |
| Drug | AC1L3X17 | 7.59e-05 | 25 | 12 | 2 | CID000123644 | |
| Drug | 8-HETE | 8.22e-05 | 26 | 12 | 2 | CID000001898 | |
| Drug | AC1L3WDO | 8.22e-05 | 26 | 12 | 2 | CID000123344 | |
| Drug | lithium dimer | 8.22e-05 | 26 | 12 | 2 | CID000139759 | |
| Drug | 11-HETE | 8.22e-05 | 26 | 12 | 2 | CID000001406 | |
| Drug | 20-hydroxyleukotriene B4 | 8.22e-05 | 26 | 12 | 2 | CID000001589 | |
| Drug | hematoporphyrin | 8.87e-05 | 27 | 12 | 2 | CID000011103 | |
| Drug | SC-41930 | 8.87e-05 | 27 | 12 | 2 | CID000114999 | |
| Drug | Bhpp | 8.87e-05 | 27 | 12 | 2 | CID000164136 | |
| Drug | BW A4C | 8.87e-05 | 27 | 12 | 2 | CID006438354 | |
| Drug | L-649,923 | 9.55e-05 | 28 | 12 | 2 | CID000119331 | |
| Drug | AC1L1G9E | 9.55e-05 | 28 | 12 | 2 | CID000003586 | |
| Drug | 13-epi-12-oxo-phytodienoic acid | 1.03e-04 | 29 | 12 | 2 | CID000188366 | |
| Drug | nafazatrom | 1.03e-04 | 29 | 12 | 2 | CID000042923 | |
| Drug | 1wbv | 1.10e-04 | 30 | 12 | 2 | CID005326870 | |
| Drug | 12-hydroxyheptadecatrienoic acid | 1.17e-04 | 31 | 12 | 2 | CID000001414 | |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 5089_UP | |
| Drug | (Z)-7-[(1R,2R,3R)-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-3-methyl-5-oxocyclopentyl]hept-5-enoic acid | 1.33e-04 | 33 | 12 | 2 | CID009548573 | |
| Drug | U-62066 [87151-85-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 4553_UP | |
| Drug | ICI 198,615 | 1.42e-04 | 34 | 12 | 2 | CID000115219 | |
| Drug | diclofenac | 1.58e-04 | 209 | 12 | 3 | CID000003032 | |
| Drug | tsuwabukinonol | 1.68e-04 | 37 | 12 | 2 | CID006440419 | |
| Drug | sIL-4R | 1.68e-04 | 37 | 12 | 2 | CID000059757 | |
| Drug | 11,14,15-THET | 1.87e-04 | 39 | 12 | 2 | CID006439531 | |
| Drug | tricarbon | 1.87e-04 | 39 | 12 | 2 | CID006432003 | |
| Drug | REV 5901 | 1.87e-04 | 39 | 12 | 2 | CID000005059 | |
| Drug | benoxaprofen | 2.06e-04 | 41 | 12 | 2 | CID000039941 | |
| Drug | AC1L1H1K | 2.06e-04 | 41 | 12 | 2 | CID000003935 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 2.17e-04 | 42 | 12 | 2 | CID006439610 | |
| Drug | AC1MRR4N | 2.27e-04 | 43 | 12 | 2 | CID003522488 | |
| Drug | 12-HPETE | 2.27e-04 | 43 | 12 | 2 | CID000001415 | |
| Drug | BAY X 1005 | 2.27e-04 | 43 | 12 | 2 | CID000123723 | |
| Drug | AC1L1JAX | 2.38e-04 | 44 | 12 | 2 | CID000004958 | |
| Drug | amsacrine | 2.49e-04 | 45 | 12 | 2 | CID000002179 | |
| Drug | VML 295 | 2.49e-04 | 45 | 12 | 2 | CID000177941 | |
| Drug | phenidone | 2.60e-04 | 46 | 12 | 2 | CID000007090 | |
| Drug | 8-isoprostaglandin E1 | 2.71e-04 | 251 | 12 | 3 | CID000000214 | |
| Drug | hexanal | 2.72e-04 | 47 | 12 | 2 | CID000006184 | |
| Drug | AC1L1DS5 | 2.83e-04 | 48 | 12 | 2 | CID000002483 | |
| Drug | 5-ASA | 3.08e-04 | 50 | 12 | 2 | CID000004075 | |
| Drug | AC1L1C7C | 3.08e-04 | 50 | 12 | 2 | CID000001772 | |
| Disease | ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 | 1.26e-07 | 2 | 11 | 2 | C1855792 | |
| Disease | Autosomal recessive congenital ichthyosis 2 | 1.26e-07 | 2 | 11 | 2 | cv:C3888093 | |
| Disease | ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2 | 1.26e-07 | 2 | 11 | 2 | 242100 | |
| Disease | Self-Healing Collodion Baby | 3.79e-07 | 3 | 11 | 2 | C1855789 | |
| Disease | Ichthyosis Congenita I | 7.58e-07 | 4 | 11 | 2 | C4551630 | |
| Disease | Harlequin Fetus | 7.58e-07 | 4 | 11 | 2 | C0239849 | |
| Disease | Collodion Fetus | 7.58e-07 | 4 | 11 | 2 | C3543867 | |
| Disease | Ichthyosis Congenita II | 7.58e-07 | 4 | 11 | 2 | C3536797 | |
| Disease | Congenital ichthyosis | 1.26e-06 | 5 | 11 | 2 | C0020758 | |
| Disease | Congenital ichthyosis of skin | 6.94e-06 | 11 | 11 | 2 | cv:C0020758 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 6.94e-06 | 11 | 11 | 2 | C0079154 | |
| Disease | melanoma | 9.70e-04 | 126 | 11 | 2 | EFO_0000756 | |
| Disease | lung adenocarcinoma | 1.84e-03 | 174 | 11 | 2 | EFO_0000571 | |
| Disease | neuritic plaque measurement | 7.15e-03 | 349 | 11 | 2 | EFO_0006798 | |
| Disease | Myopia | 8.64e-03 | 385 | 11 | 2 | HP_0000545 | |
| Disease | PR interval | 1.40e-02 | 495 | 11 | 2 | EFO_0004462 | |
| Disease | electrocardiography | 1.59e-02 | 530 | 11 | 2 | EFO_0004327 | |
| Disease | QT interval | 1.61e-02 | 534 | 11 | 2 | EFO_0004682 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAPWIMTPNTQPPEE | 291 | Q9ULC6 | |
| AIGWMPVANCPMPLA | 16 | Q9UK17 | |
| NMLPAGNPWLQMPTI | 361 | Q96LI6 | |
| AQPMAPPAQPMASWA | 316 | Q9UJ55 | |
| SPSQMFPWMRPQAAP | 181 | P13378 | |
| WMPNAPSSMRQPPPQ | 601 | Q9BYJ1 | |
| APSSSPDSWNNPVMM | 471 | Q14432 | |
| MDGKMQPNSFPWQSP | 216 | Q9BZF3 | |
| WMPNFPASMRNPPIQ | 591 | O75342 | |
| MAPPWVPAMGFTLAP | 1 | P30536 | |
| MLPEQGPQPSTMPLW | 1 | Q6UXV3 | |
| FGTVPPQMMFPPNWQ | 36 | P20592 | |
| PVNMGWATPNMAAHP | 446 | Q96HR8 |